Gsa Capital Partners LLP Glaukos Corp Transaction History

Gsa Capital Partners LLP

$1.35 Billion
Q4 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 15, 2023	BUY	$69.23 - $79.09 $530,717 - $606,303	7,666 New	7,666 $576,000
Q1 2023 May 12, 2023	SELL	$43.88 - $52.48 $252,924 - $302,494	-5,764 Reduced 44.36%	7,229 $362,000
Q4 2022 Feb 13, 2023	BUY	$40.82 - $57.75 $530,374 - $750,345	12,993 New	12,993 $568,000
Q4 2021 Feb 14, 2022	SELL	$40.27 - $56.99 $625,715 - $885,510	-15,538 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$47.43 - $84.23 $542,694 - $963,759	11,442 Added 279.35%	15,538 $748,000
Q2 2021 Aug 05, 2021	BUY	$73.06 - $97.7 $299,253 - $400,179	4,096 New	4,096 $347,000
Q1 2021 May 10, 2021	SELL	$70.43 - $97.42 $313,765 - $434,006	-4,455 Closed	0 $0
Q4 2020 Feb 03, 2021	BUY	$48.9 - $75.26 $217,849 - $335,283	4,455 New	4,455 $335,000
Q4 2019 Feb 12, 2020	SELL	$54.18 - $65.64 $243,105 - $294,526	-4,487 Closed	0 $0
Q3 2019 Nov 12, 2019	SELL	$58.58 - $83.91 $268,589 - $384,727	-4,585 Reduced 50.54%	4,487 $280,000
Q2 2019 Aug 06, 2019	SELL	$63.59 - $78.71 $306,122 - $378,909	-4,814 Reduced 34.67%	9,072 $684,000
Q1 2019 May 15, 2019	SELL	$50.75 - $80.54 $650,107 - $1.03 Million	-12,810 Reduced 47.98%	13,886 $1.09 Million
Q4 2018 Feb 12, 2019	SELL	$52.18 - $67.93 $222,391 - $289,517	-4,262 Reduced 13.77%	26,696 $1.5 Million
Q3 2018 Nov 13, 2018	SELL	$38.13 - $68.37 $5,414 - $9,708	-142 Reduced 0.46%	30,958 $2.01 Million
Q2 2018 Aug 09, 2018	SELL	$27.62 - $44.51 $1.32 Million - $2.12 Million	-47,662 Reduced 60.51%	31,100 $1.26 Million
Q1 2018 May 11, 2018	SELL	$26.05 - $34.5 $1.7 Million - $2.26 Million	-65,406 Reduced 45.37%	78,762 $2.43 Million
Q4 2017 Feb 14, 2018	BUY	$24.5 - $36.01 $3.05 Million - $4.48 Million	124,450 Added 631.15%	144,168 $3.7 Million
Q3 2017 Nov 20, 2017	BUY	$31.26 - $42.03 $616,384 - $828,747	19,718	19,718 $651,000

Others Institutions Holding GKOS

# of Institutions

355

Shares Held

47.8M

Call Options Held

124K

Put Options Held

185K

Black Rock Inc. New York, NY

8.04M
Shares

$1.21 Billion
0.02% of portfolio
Vanguard Group Inc Valley Forge, PA

5.97M
Shares

$896 Million
0.02% of portfolio
Wellington Management Group LLP Boston, MA

2.18M
Shares

$328 Million
0.05% of portfolio
State Street Corp Boston, MA

1.95M
Shares

$293 Million
0.01% of portfolio
Ameriprise Financial Inc Minneapolis, MN

1.64M
Shares

$246 Million
0.06% of portfolio

View Full List

About GLAUKOS Corp

Ticker GKOS
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 47,596,900
Market Cap $7.14B
Description
Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...

More about GKOS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gsa Capital Partners LLP, based on Form 13F filings with the SEC.

News

Stay updated on Gsa Capital Partners LLP with notifications on news.

Account